Marek Cmero

5PUBLICATIONS
88CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 13, 2025
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Takafumi N Yamaguchi, Kathleen E Houlahan, Helen Zhu

|Dec 09, 2022
Author Correction: Inferring structural variant cancer cell fraction.

Marek Cmero, Ke Yuan, Cheng Soon Ong

|Jun 10, 2021
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.

Patrick McCoy, Stefano Mangiola, Geoff Macintyre

|Feb 07, 2020
Inferring structural variant cancer cell fraction.

Marek Cmero, Ke Yuan, Cheng Soon Ong

|Jun 04, 2019
Using equivalence class counts for fast and accurate testing of differential transcript usage.

Marek Cmero, Nadia M Davidson, Alicia Oshlack

Pageof 1

Frequent Collaborators

3 joint publications

Tony Papenfuss

2 joint publications

Ken Chow

2 joint publications

Ke Yuan

2 joint publications

Cheng Soon Ong